Addiction Flashcards

1
Q

relationship between the access and use of a drug

A

Easier access to drug = greater use of the drug (think about the rates of alcohol use below, the lower rates are in Islamic countries where it is illegal to drink).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a ‘safe’ level of alcohol consumption?

A
  • Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden Study 2016
  • Common alcohol consumption: Griswold et al. 2016
  • None is the ‘safe’ level of alcohol consumption!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

alcoholism in England stats

A

o 1 million people
o 4% of the adult population
 2% of women, 6% of men (3x more common in men)
 Most (90%+) not receiving treatment
o 24% of adults consume in excess of recommended limits
o 27% binge drink
o Alcohol misuse is the biggest risk factor for death, ill health and
disability among 15-49 year-olds in the UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does alcohol (ethanol) work?

A
  • Weak and dirty drug
  • No specific receptor?
  • Affects ion channels
    o GABA receptor (inhibitory) – turns them up
    o NMDA receptors (excitatory) – turns them down (hyperpolarisation)
    o Calcium channels (excitatory) – turns them down (so less AP fired and NT released)
    o Many other molecular effects
  • 2 major functional neuronal targets (see right)
    o GABA receptor potentiates inhibition
    o VOCC (Ca) receptor and NMDA receptor reduces excitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GABA receptors role

A
  • Effect of GABA is potentiated by positive (makes GABA receptor work more efficiently) allosteric (binds elsewhere to where GABA binds) modulators
  • GABA binds at the surface, other drugs bind elsewhere
  • Makes GABA more effective (more GABA comes in when alcohol binds)
    o BZs have the same effect
    o Additive effects (it is why you often cannot drink when taking medication)
  • Chloral hydrate (one of the first positive allosteric modulators)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute pharmacodynamics of ethanol:

A
  • Increase inhibitory pathways (GABA)
    o EtOH allosterically potentiates GABA receptors
    o EtOH + benzodiazepine effects additive
    o Important for acute intoxication
  • Decrease excitatory pathways (Glutamate)
    o EtOH inhibits NMDA receptor activity
     most sensitive ethanol effect-
     important in acute intoxication, memory loss (blackouts)
    o Calcium channels
  • These increases/decreases occur everywhere in the brain!
    o Impaired functioning in the cerebellum
     Loss of coordination, including speech (ataxia)
    o Impaired functioning in the prefrontal cortex
     Working memory impaired
     Executive functioning (inhibition of decision-making, reduces social inhibitions – makes decisions quicker (impulsivity))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

parts of brain damaged in wernickes encephalopathy

A

o Medial thalamus (memory problems)
o Hypothalamus (basic physiology)
o Mamillary bodies (memory problems)
o Cerebellum (Ataxia)
o Prefrontal Cortex (Executive Function and memory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

causes of wernickes encephalopathy

A
  • Most common cause is vitamin B1 deficiency
    o Chronic alcoholism
     Unable to absorb vitamin B1 (thiamine)
     Direct toxicity of alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

treatment for wernickes encephalopathy

A

IV thiamine (if caught early enough)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Korsakoff’s psychosis
A

o Consequence of Wernickes Encephalopathy
o Irreversible damage to Medial thalamus + Mamillary bodies
o Anterograde AND retrograde amnesia
o Confabulation (Confusion between memory and imagination)
o Little or no recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alcohol flush reaction: ‘Asian Flush’

A
  • ~40% of East Asians
  • Aldehyde Dehydrogenase does not work as well (remove this from the diagram above between aldehyde and acetate), so acetaldehydes cannot be metabolised
  • Acetaldehyde accumulates
  • Alcohol very aversive
  • Lower rates of alcoholism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

tolerance

A
  • Tolerance: Decreased response to set drug concentration after continued use
    o Compensatory homeostatic systems adapt to drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dependence

A
  • (physical) Dependence: Stopping drug causes withdrawal, via compensatory homeostatic systems.
    o Can occur with non-addictive drugs (eg; vasoconstrictors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

addiction

A
  • Addiction: Continued drug use despite known adverse consequences.
    o Compulsive drug-seeking behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

relapse

A
  • Relapse: Resumption of (problematic) drug use after trying to stop taking drugs.
    o Can occur in the absence of tolerance + dependence, months/years after stopping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

chronic tolerance

A
  • Results from long-term ethanol exposure
  • Higher dose required to achieve same effect
  • Significant increase in number and activity of enzymes that metabolise ethanol
  • Long-lasting changes in abundance and function of those targets affected by acute ethanol exposure
17
Q

acute tolerance

A
  • Drinking yourself sober (clinically and legally important)
  • Occurs ‘within-session’
    o Same basic mechanisms as chronic tolerance – changes in function of GABA/NMDA receptors
  • Consequences of acute functional tolerance:
    o Not good because they may feel fine but blood alcohol would still be too high
18
Q

Himmelsbach hypothesis:

A
  • Mechanisms of tolerance and withdrawal
    o Withdrawal happens when adaptions that cause tolerance are expressed without drug on board
    o Crudely; symptoms of withdrawal are opposite of acute drug effects
19
Q

Alcohol withdrawal syndrome:

A
  • Can be fatal
  • Many alcoholics are very afraid of withdrawal
  • Abrupt cessations after chronic use:
    o motor agitation, anxiety, insomnia, reduction in seizure threshold (after acute use)
    o delirium tremens (after going into withdrawal)
     Hallucinations, tremor, hyperpyrexia, sympathetic hyperactivity, death
  • Treatment options: ‘hair of the dog’ – works (Himmelsbach hypothesis), BZs most commonly used in the clinic instead (chlordiazepoxide).
    o BZs work to treat alcohol withdrawal in the same way as the hair of the dog principle and can be explained by the Himmelsbach hypothesis.
  • Hangover is basically a mild case of alcohol withdrawal syndrome.
    o Have become acutely tolerant and feel a reduction in anxiety and seizure threshold, and then the next day you go into withdrawal.
20
Q

withdrawal

A
  • Most physical withdrawal syndromes resolve quickly (under 2 weeks)
    o Alcohol, opiates, nicotine, benzodiazepines
    o “Getting clean” or “detox” is relatively straightforward
  • Relapse possible months or years later
    o Stress, cues associated with drug use
  • Some highly addictive drugs have no obvious physical withdrawal syndrome
    o psychostimulants
21
Q
  • 2 major types (Ball, 1996) of alcoholism
A

Type A/1 Type B/1

  • Type 2/B is harder to treat
22
Q
  • Treatments used in the management of alcoholism:
A

o Acamprosate
o BZs
o CBT
o Disulfiram (blocks alcohol metabolism to make them less likely to drink)
o Naltrexone (reduced addiction cravings)

23
Q

nocotine addiction

A

o More people addicted to nicotine than anything else
o Stimulant and depressant
o Effects mediated by nicotinic acetylcholine receptors
 Many different subtypes
 CNS and PNS

24
Q
  • Psychostimulant ‘empathogens’ addiction
A

o MDMA (Ecstasy), 4-MMC (Mephedrone)
o Mixed psychostimulant and ‘hallucinogen’ properties
o Legal until recently
o Addictive profiles uncertain; MDMA probably not
o Overdose possible?

25
Q

replacement therapy

A
  • Replace a fast-acting drug/prep with a slow one:
    o Addictive drugs
     Fast on, fast off (e.g. cigarettes)
     Short duration
     Strong
     Route of admin affects all four
    o Replacement therapy
     Replace with slow on/off
     Nicotine, opioids, BZs
     Doesn’t work very well
26
Q

Mesolimbic dopamine pathway:

A
  • Dopamine neurons in Ventral Tegmental Area
    o Part of midbrain (A)
  • Project to Ventral Striatum
    o Nucleus Accumbens
    o Via Medial Forebrain Bundle
27
Q

Intracranial self-stimulation: short-circuiting reward:

A
  • Olds and Milner, 1954
  • Stimulating electrodes in Medial Forebrain Bundle
    o Activated when rat presses lever
  • Rats learned to press lever to stimulate MFB
  • Once learned, did not stop
  • Deprioritised all other behaviours
  • Similar findings in humans
28
Q

Reward circuit (motivation circuit): Schultz, 2016

A

Dopamine neurons – reward prediction error
- “Rewards” stimulate release of dopamine
o Unexpected rewards are most potent
o More unexpected rewards = more dopamine
- Dopamine acts as a learning signal
o Environmental cues which predict reward will cause dopamine release
o (reward itself does not cause dopamine release)
o If reward is not obtained, dopamine neurons are inhibited
- The actions of this circuit ensure
o We learn about rewards
 Especially the environment in which they may be found
o We are highly motivated to obtain them
- Dopamine neurons are activated by molecular correlates of reward

29
Q

Reward and endogenous opioids:

A
  • Endogenous Opioids are Peptide Neuromodulators
  • Tonic firing of dopamine neurons is subject to inhibition from GABAergic interneurons
  • Endorphins inhibit GABA release from interneurons
  • Less inhibition of dopamine neurons
    o Double negative
    o Dopamine neurons fire more often
    o equals more dopamine release
30
Q

gambling addiction comorbidity

A

50%+ seeking treatment for gambling disorder screen positive for substance use disorder (Grant and Chamberlain 2016)